Sep 1, 2008 By:
Mari Edlin
|
Will generic drugs, patent expirations, safety issues and a dry pipeline for high-incident diseases make room for a new drug paradigm?

Coinsurance seems to be on the rise, but many plans stick to copays and tiered models to ensure compliance Aug 1, 2008 By:
Mari Edlin
|
A recent online survey from Serono Injectables Digest, which includes data from 83 health plans, looked at the challenges and strategies of managing specialty pharmacy, provider reimbursement and cost sharing.

Jul 1, 2008 By:
Elaine Zablocki
|
Statin medications lower cholesterol levels and have an anti-inflammatory effect. They should be used in combination with lifestyle changes to reduce heart disease risk.

Programs track prescribing patterns, match claims against certain criteria, alert physicians to potential problems May 1, 2008 By:
Mari Edlin
|
How much attention is being paid to abuse of prescription drugs? One group, pharmacy benefit managers, are beginning to take a closer look by creating programs to identify members who may be abusing prescription drugs.

New draft guidance would allow drug companies to put off-label information in the hands of physicians Apr 1, 2008 By:
Mari Edlin
|
Using drugs for conditions other than what's on the label is not new, but it may receive more encouragement if draft guidance from the Food & Drug Administration (FDA) is approved. Allowing more off-label use might also increase payers' pharmacy costs.

Mar 1, 2008 By:
Mari Edlin
|
MEDICATION THERAPY Management (MTM) services introduced in 2006 under Medicare Part D have prompted pharmacists to adopt expanded roles in the commercial setting, such as performing a comprehensive medication review and monitoring a patient's response to therapy. One of the main caveats, however, is the lack of standardized reimbursement for pharmacists' services.

Diagnosis of behavioral health conditions is not an exact science, so trial and error Feb 1, 2008 By:
Mari Edlin
|
Studies show that patients with behavioral health conditions are less apt to be compliant with medications than other patients, but many of their reasons for non-compliance are equally applicable to all drugs.

Rigorous scientific process will be needed to approve generic biologics for drug interchangeability Jan 1, 2008 By:
Mari Edlin
|
Biogenerics will not be taking the U.S. marketplace by storm any time soon. Approval of biogenerics is creating a rift between innovators and generic manufacturers and is putting data exclusivity and interchangeability to the test

PBMs train pharmacists to provide patients higher levels of care management when using mail services Dec 1, 2007 By:
Mari Edlin
|
What works for retail pharmacy patients should work for mail-order recipients, namely, personalized drug counseling. When consumers pick up their prescriptions at a local pharmacy, they have access to pharmacists who can advise them on how and when to take medications, warn them of potential side effects and discuss generic alternatives.
